Last Posted: Oct 13, 2021
- Pro-inflammatory and anti-inflamatory cytokine genes polymorphisms and susceptibility to Japanese encephalitis disease in the North Indian population.
Ghildiyal Sneha, et al. Cytokine 2021 10 155716
- Association of single nucleotide polymorphisms in TNFA and CCR5 genes with Japanese Encephalitis: A study from an endemic region of North India.
Deval Hirawati, et al. Journal of neuroimmunology 2019 8 577043
- Association of ICAM-1 (K469E) and MCP-1-2518 A?>?G polymorphism with risk of Japanese encephalitis in North Indian population.
Baluni Manjari, et al. Cytokine 2018 6
- Significance of CCL2, CCL5 and CCR2 polymorphisms for adverse prognosis of Japanese encephalitis from an endemic population of India.
Chowdhury Purvita, et al. Scientific reports 2017 10 (1) 13716
- Toll-like receptor-3 gene polymorphism in patients with Japanese encephalitis.
Biyani Sumant, et al. Journal of neuroimmunology 2015 9 71-6
- TNF-a promoter polymorphism: a factor contributing to the different immunological and clinical phenotypes in Japanese encephalitis.
Pujhari Sujit Kumar, et al. BMC infectious diseases 2012 0 (1) 23
- Japanese encephalitis
From NCATS Genetic and Rare Diseases Information Center
- Polymorphisms of the gene coding for copper/zinc superoxide dismutase (SOD1) in patients with Japanese encephalitis.
Thuong N T T, et al. Annals of tropical medicine and parasitology 2006 10 (7) 631-6
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.